medigraphic.com
Instituto Nacional de Salud Pública

2022, Number 1

<< Back Next >>

salud publica mex 2022; 64 (1)

Developing a collaborative international partnership for cancer control in Mexico

Van Loon K, Mohar A, Unger-Saldaña K, Potter MB, Sweet-Cordero EA, Breithaupt L, Espinosa-Tamez P, Sepúlveda-Amor J, Lajous M

Language: English
References: 19
Page: 100-104
PDF size: 190.49 Kb.


ABSTRACT

In 2014, a partnership was established between the University of California and Mexico, which subsequently catalyzed formation of collaborations between cancer researchers at University of California, San Francisco and in Mexico. Over the past two decades cancer burden has dramatically increased in Mexicans on both sides of the California - Mexico border. Together, we face a growing burden of cancer in the context of globalized economies, diverse migration patterns, and dynamic immigration policies. Our partnership aims to: 1) understand the life course impact of cancer risk factors and interactions with changing environments; 2) address cancer disparities within Mexico, in Mexican migrants to the United States, and in naturalized Mexican-Americans; and 3) identify effective cancer screening strategies and cancer control policies that are tailored to existing healthcare systems and social and cultural factors. Herein, we describe the principles of partnership and early successes and challenges of this collaboration.


REFERENCES

  1. Napolitano J. UC initiative with Mexico shows advantages of cooperation over confrontation. The Sacramento Bee [internet], 2017 [cited 2020 Dec 15]. Available from: https://www.sacbee.com/opinion/op-ed/soapbox/ article142965104.html

  2. Martinez C, Leal G. The epidemiological transition in Mexico: a case of poorly designed health policies and lack of evidence. Demogr Urban Stud. 2002;17(3):547-69. http://doi.org/10.24201/edu.v17i3.1150

  3. Barquera S, Tolentino L. Geography of the diseases associated with nutrition in Mexico: a perspective of epidemiological transition. Pap Poblac. 2005;11(43):133-48. Available from: http://www.scielo.org.mx/scielo. php?pid=S1405-74252005000100006&script=sci_abstract&tlng=en

  4. Soto-Perez-de-Celis E, Chavarri-Guerra Y. National and regional breast cancer incidence and mortality trends in Mexico 2001-2011: Analysis of a population-based database. Cancer Epidemiol. 2016;41:24-33. https://doi. org/10.1016/j.canep.2016.01.007

  5. Mohar-Betancourt A, Reynoso-Noverón N, Armas-Texta D, Gutiérrez- Delgado C, Torres-Domínguez JA. Cancer trends in Mexico: essential data for the creation and follow-up of public policies. J Glob Oncol. 2017;3(6):740-8. https://doi.org/10.1200/JGO.2016.007476

  6. Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36(1):25-33. https://doi.org/10.1200/JCO.2017.74.2049

  7. Instituto Nacional de Cancerología. Programa Integral de Prevención y Control del Cáncer en México. México City: Instituto Nacional de Cancerología, 2016.

  8. Ramirez AG, Villarreal R, Suarez L, Flores ET. The emerging Hispanic population: a foundation for cancer prevention and control. J Natl Cancer Inst Monogr. 1995;18:1-9. Available from: https://pubmed.ncbi.nlm.nih. gov/8562207/

  9. Miller KD, Goding-Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero- Luna G, et al. Cancer Statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018;68(6):425-45. https://doi.org/10.3322/caac.21494

  10. Pew Hispanic Center. Latinos in California, Texas, New York, Florida and New Jersey. Washington DC: Hispanic, 2004.

  11. United States Census Bureau. Population estimates. Washington DC: The United States Census Bureau, 2019.

  12. Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, et al. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58(2):118–31. https://doi.org/10.21149/spm.v58i2.7780

  13. Reynoso-Noverón N, Meneses-García A, Erazo-Valle A, Escuderode los Ríos P, Kuri-Morales PA, Mohar-Betancourt A. Challenges in the development and implementation of the National Comprehensive Cancer Control Program in Mexico. Salud Publica Mex. 2016;58(2):325-33. https://doi.org/10.21149/spm.v58i2.7804

  14. Institute for Health Metrics and Evaluation, Global Burden of Disease U of WS. GBD Compare Data Visualization. Seattle: University of Washington Press, 2017.

  15. Remes-Troche JM, Hinojosa-Garza G, Espinosa-Tamez P, Meixueiro-Daza A, Grube-Pagola P, Van Loon K, et al. Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience. Fam Pract. 2020;37(3):321-4. https://doi.org/10.1093/fampra/cmz078

  16. Manzano-Robleda MDC, Espinosa-Tamez P, Potter MB, Lajous M, Van Loon K, Zhang L, et al. Fecal Immunologic test results and diagnostic colonoscopy in a Mexican population at average risk for colorectal cancer. Cancer Prev Res. 2020;13(11):959-66. https://doi.org/10.1158/1940-6207. CAPR-20-0076

  17. Unger-Saldaña K, Saldaña-Tellez M, Potter MB, Van Loon K, Allen-Leigh B, Lajous M. Barriers and facilitators for colorectal cancer screening in a low-income urban community in Mexico City. Implement Sci Commun. 2020;1(1):64. https://doi.org/10.1186/s43058-020-00055-z

  18. Koplan JP, Bond TC, Merson MH, Reddy KS, Rodriguez MH, Sewankambo NK, et al. Towards a common definition of global health. Lancet. 2009;373(9679):1993-5. https://doi.org/10.1016/S0140- 6736(09)60332-9

  19. Barquera S, Schillinger D, Aguilar-Salinas CA, Schenker M, Rodríguez LA, Hernández-Alcaraz C, et al. Collaborative research and actions on both sides of the US-Mexico border to counteract type 2 diabetes in people of Mexican origin. Global Health. 2018;14(1):84. https://doi. org/10.1186/s12992-018-0390-5




2020     |     www.medigraphic.com